Akira Okada

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Risk Assessment

Electronic Health Record

Cross Sectional

Top Venues

BMC pharmacology & toxicology

Science progress

The Annals of pharmacotherapy

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Akira Okada, Shoji Sera, Naomi Nagai
Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data. BMC pharmacology & toxicology 25 (1) (2024)
Akira Okada, Shoji Sera, Naomi Nagai
Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data. BMC pharmacology & toxicology 25 (1) (2024)
Akira Okada, Shoji Sera, Maho Taguchi, Hiroaki Yamada, Naomi Nagai
Current status and usefulness of therapeutic drug monitoring implementation of theophylline in elderly patients based on a nationwide database study and modeling approach. Science progress 107 (3) (2024)
Akira Okada, Shoji Sera, Maho Taguchi, Hiroaki Yamada, Naomi Nagai
Analysis of drug adverse events in elderly patients based on the Japanese Adverse Drug Event Report Database. Journal of clinical pharmacy and therapeutics 47 (8) (2022)
Koki Takeda, Chika Kobayashi, Taketo Nakai, Teruki Oishi, Akira Okada
Analysis of the Frequency and Onset Time of Hyponatremia/Syndrome of Inappropriate Antidiuretic Hormone Induced by Antidepressants or Antipsychotics. The Annals of pharmacotherapy (2021)